Lobe Sciences Ltd. Acquires Altemia & Company, LLC

August 30, 2023

Lobe Sciences Ltd. signed an amendment to its share purchase agreement to acquire a 100% interest in Altemia & Company, LLC, including assets, know‑how, IP and commercial inventory related to Altemia, a medical food for sickle cell disease. The amended terms provide for the return and milestone-based reissuance of 76,000,000 Lobe common shares to the Altemia selling members upon achievement of specified development, delivery, commercial sale and tech-transfer milestones.

Buyers
Lobe Sciences Ltd.
Targets
Altemia & Company, LLC
Sellers
Altemia & Company, LLC, Altemia members (Selling Members)
Industry
Biotechnology
Location
Florida, United States
Transaction Type
Buyout

Explore More

Related articles

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.

Find buyers like these →